Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.50    0.50 (0.22%)
Bid:
228.50
Ask:
229.00
Spread: 0.50 (0.219%)
Market Cap: £631.61m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Acquisition

14 Jan 2011 07:00

RNS Number : 4588Z
Morgan Crucible Co PLC
14 January 2011
 



 

 

For Immediate Release

14 January 2011

 

Morgan Crucible Acquires Leading Graphite Supplier to Lithium Ion Market

 

The Morgan Crucible Company plc (Morgan Crucible) announced today that it has completed its acquisition of Changsha Hairong New Materials Co., Ltd. (Hairong) in Changsha, China for 64m RMB (£6.15m) in cash from Hunan Caixin Venture Investment Co., Ltd, a local Chinese government entity (51%), three individual investors and two senior managers. The acquisition was made by Shanghai Morgan Carbon Co., Ltd, a joint venture company in which Morgan Crucible has a controlling 70% stake, the remaining 30% being owned by Shanghai Prime Machinery Co Ltd, itself a subsidiary of The Shanghai Electric Group.

 

Hairong, which has been renamed Morgan AM&T Hairong Co., Ltd., is a recognised technical leader in the production of graphite materials for anodes used in lithium ion batteries for portable electronics and electric vehicles. Revenues of the business are forecast to be in excess of 52m RMB (£5m) in 2011 at mid teen operating profit margins.

 

"Morgan has been actively developing advanced anode material technology for the lithium ion market," said Mark Robertshaw, CEO of Morgan Crucible. "The addition of Hairong to the Morgan Group fits with our strategic priorities and brings with it the opportunity to benefit from China's expanding demand for electric vehicles and energy storage. Hairong has established itself as the leading supplier of high performance anode materials to the major lithium ion battery companies in China that serve these burgeoning new markets."

 

"This acquisition complements the Engineered Materials Division's expanding reach into the renewable energy sector and provides another exciting platform for future growth both in the Chinese domestic market and through the Division's global footprint" said Don Klas, CEO of Morgan Crucible's Engineered Materials Division.

 

For further enquiries:

Mark Robertshaw Morgan Crucible 01753 837000

Kevin Dangerfield

 

Rollo Head/Clare Hunt Finsbury 0207 251 3801

 

 

Notes to Editors: Morgan Crucible (www.morgancrucible.com) is an advanced materials technology company that provides highly engineered solutions to its chosen markets. Morgan Crucible has a global presence with operations in more than 50 countries. From medical instruments, aerospace, power generation and satellite communications, to body armour, trains and fire protection systems, Morgan Crucible's products are fundamental components or enabling technologies for many of the modern world's sophisticated products.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXFDFSXFEFF
Date   Source Headline
19th Sep 201610:52 amRNSDirector/PDMR Shareholding
13th Sep 201611:43 amRNSDirector/PDMR Shareholding
23rd Aug 20163:59 pmRNSHolding(s) in Company
28th Jul 201611:40 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSHalf-Year Results
29th Jun 20161:19 pmRNSHolding(s) in Company
29th Jun 20161:16 pmRNSHolding(s) in Company - Amendment
22nd Jun 201611:59 amRNSHolding(s) in Company
20th Jun 201611:22 amRNS2015 Environmental, Health and Safety Report
15th Jun 201610:18 amRNSBlock listing Interim Review
31st May 20162:55 pmRNSDirector/PDMR Shareholding
24th May 201612:31 pmRNSDirector/PDMR Shareholding
6th May 20162:23 pmRNSResult of AGM
6th May 20167:00 amRNSTrading update
18th Apr 20162:39 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAppointment of Non-Executive Director
7th Apr 20164:30 pmRNSDirector/PDMR Shareholding
6th Apr 20161:18 pmRNSAnnual Financial Report
5th Apr 20167:00 amRNSDirectorate Change
30th Mar 20167:00 amRNSAppointment of Chief Financial Officer
24th Mar 20167:00 amRNSBoard Change
24th Feb 20161:08 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSFinal Results
4th Feb 201610:56 amRNSDirectorate Change
1st Feb 20161:56 pmRNSDirector Declaration
22nd Jan 20167:00 amRNSAppointment of a Non-Executive Director
14th Jan 201612:33 pmRNSHolding(s) in Company
30th Dec 201510:10 amRNSDirector/PDMR Shareholding
18th Dec 20152:22 pmRNSDirector/PDMR Shareholding
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.